Determinants for the development of visceral leishmaniasis disease - sprookjes - yvandenbroek - TriplyDB

Determinants for the development of visceral leishmaniasis disease

Determinants for the development of visceral leishmaniasis disease

http://www.wikidata.org/entity/Q27027871

about

Multilocus microsatellite typing of Leishmania and clinical applications: a review Abortive T follicular helper development is associated with a defective humoral response in Leishmania infantum-infected macaques Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil.Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain.Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids.Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines Cross-species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector.Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis Xenodiagnosis of Leishmania donovani in BALB/c mice using Phlebotomus orientalis: a new laboratory model.Northalrugosidine is a bisbenzyltetrahydroisoquinoline alkaloid from Thalictrum alpinum with in vivo antileishmanial activity The Leishmania metaphylome: a comprehensive survey of Leishmania protein phylogenetic relationships Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.Natural hybrid of Leishmania infantum/L. donovani: development in Phlebotomus tobbi, P. perniciosus and Lutzomyia longipalpis and comparison with non-hybrid strains differing in tissue tropism.Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection Antileishmanial and Cytotoxic Activity of Some Highly Oxidized Abietane Diterpenoids from the Bald Cypress, Taxodium distichum Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.Iron in intracellular infection: to provide or to deprive?The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Histological and parasitological distinctive findings in clinically-lesioned and normal-looking skin of dogs with different clinical stages of leishmaniosis.Imaging host-Leishmania interactions: significance in visceral leishmaniasis.Pathways of iron acquisition and utilization in Leishmania.Dysfunctional adaptive immunity during parasitic infections Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.Phlebotomine sand fly-borne pathogens in the Mediterranean Basin: Human leishmaniasis and phlebovirus infections.Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.Host resistance to visceral leishmaniasis: prevalence and prevention.A case report of isolated lymphadenopathy revealing localized leishmanial lymphadenopathy in an asthenic 25-year-old man Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.Visceral leishmaniasis: a forgotten epidemic.Phenotypic Characterization of a Leishmania donovani Cyclophilin 40 Null Mutant.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Variability of Cutaneous Leishmaniasis Lesions Is Not Associated with Genetic Diversity of Leishmania tropica in Khyber Pakhtunkhwa Province of Pakistan.Using humans to make a human leishmaniasis vaccine.Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA Lipidomic alterations of in vitro macrophage infection by L. infantum and L. amazonensis.

P2860

Q22810163-6CECE2B6-73CB-4FAC-87C3-AA42E868AAF9 Q27326637-4D1F18DF-5262-46F7-9CEA-E9A2D0DC8A4D Q28543469-CE64758D-306F-49D3-ABE1-1140B4CD6818 Q28544037-04310419-CDA6-4C24-802B-2F35D399FBC8 Q30365464-260ED9A6-A227-427B-86B1-0B54BA968ED0 Q33753224-DB8C46C3-D93F-4FDB-8E89-CBF30A414F8E Q33846006-B73A7E6F-0096-4360-8D64-5EEA2B55B2B0 Q33948805-4CEC8FD7-C3F0-40FA-A521-0AA364AA7831 Q34435696-A50EFE81-B1EA-4070-A920-D5C83676F5EF Q34601558-74623575-F5F8-4708-B3DB-CC9B76396A72 Q35122575-2465B1C8-D76A-4307-A25B-47159520C61E Q35190896-D24C3CB9-0139-4530-8F45-432C66B6F615 Q35388295-9041E341-3D94-4807-9B4B-8A6BEBE4A94B Q35827646-3145FAA0-B1B0-4B2C-AA51-2E70578FFA06 Q35890723-1E05CA82-AE7F-491D-913D-1E5192CE90A7 Q36321924-4C5AF99A-0FB7-49A2-960E-D9810CC427F6 Q36385616-93054F65-460D-402A-A0B0-E32E524A60EE Q36796525-35D4F24B-C361-4B1F-B433-033F4EE0FE5F Q37239554-068FAE4A-0D14-4851-A3C9-8C665A47FD99 Q37376232-232873F0-FB18-4B08-B042-4F78FCE4B146 Q37576360-70B275EB-B40A-4AE9-986C-BAAD98A0C3EF Q37695035-404FA48D-7EB7-4766-B7F0-C6B7F32264F8 Q38114928-1BDCB8A9-B224-476E-A898-18AE95E1D9CE Q38130388-F2DD1CE1-7234-4A90-8D6D-2718D164E47A Q38212667-EDB1B6EF-E8C9-45EE-9E3B-D44B4D2CECB4 Q38247916-23E691E9-2CFB-41E3-9AFC-40CAAF23B286 Q38406751-9275F942-B005-4981-81FA-CF0968830CA9 Q38644353-AE69DF09-8C32-4B57-8138-D6CCE04B58CC Q38710622-6CF8AE4F-3AFE-405F-B722-EF0C6F00C45D Q38757973-234E7F37-7ECE-4B09-AED9-954F88A6519E Q39088906-DFA98E5B-6B3E-4B66-9A5D-C097D709CC89 Q39240018-E94965AA-336C-4F68-A3AE-8B53DD50DBBE Q39632056-124B9272-7464-4CD5-BC69-53DF30C84BE4 Q39742401-32CC5264-CD84-43B5-B710-B3B39ECDF0AE Q41622831-F1B82B15-B29F-4B75-950D-CFA2C8A9C053 Q41989168-EFD4C1CD-97EB-4BB8-8A53-253657B03C37 Q42217105-55E76DB3-BFC3-4D8C-B57E-ADC49EA93397 Q42248079-1DF52DF3-98F7-427B-A9EC-BDD4A72DC49C Q42643381-8641ECC0-3849-482C-87FA-27E73B4BA73B Q46299161-6D73D83E-CC8A-44BE-9131-4BB09503A1B2

P2860

Determinants for the development of visceral leishmaniasis disease

http://www.wikidata.org/entity/Q27027871

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Determinants for the development of visceral leishmaniasis disease

@ast

Determinants for the development of visceral leishmaniasis disease

@en

Determinants for the development of visceral leishmaniasis disease

@nl

type

label

Determinants for the development of visceral leishmaniasis disease

@ast

Determinants for the development of visceral leishmaniasis disease

@en

Determinants for the development of visceral leishmaniasis disease

@nl

prefLabel

Determinants for the development of visceral leishmaniasis disease

@ast

Determinants for the development of visceral leishmaniasis disease

@en

Determinants for the development of visceral leishmaniasis disease

@nl

P1433

Q27027871-555BF14C-55DE-49AB-BB2E-4E3B91FAA3D3

P1476

Q27027871-80FFB0F7-E5C4-4E6B-9F1C-8EBA7D5419AB

P2093

Q27027871-5B767154-9D25-4685-B5C1-4966613E98F1

Q27027871-EDD8E0A9-A916-4BAE-99BF-02B3161EE864

Q27027871-EEEF1059-6640-4309-97BC-DC87209FB7C2

P275

Q27027871-AF292C79-B900-42EE-B2A5-77A50C4208F6

P2860

Q27027871-00F4F6F5-CFA8-413B-BB71-DB11C8A4073A

Q27027871-076D7A63-90F2-4C8E-BA45-1781D1749A7A

Q27027871-0D835EBC-0677-4D31-8502-953CFCAC1F65

Q27027871-0E7CE728-2133-4CC5-9D6C-E82C12F953B1

Q27027871-0E83A480-804A-40C4-A60E-26A6C8F81F13

Q27027871-167DC81E-5AB3-4F44-80BC-B284F5297883

Q27027871-174847C5-6D21-4C89-81BA-72A2D85B25BB

Q27027871-1A05ED34-D976-412F-934B-96C1E8486875

Q27027871-1B2EBD31-AFEA-4108-8C96-9E96B7C1819B

Q27027871-1C59C9E4-3EB5-4B76-B786-8185EF2B8697

P304

Q27027871-94316744-1253-408B-BBBF-84CB777D0CE7

P31

Q27027871-0E59F5B8-AD17-48BC-AB48-E83128FE7FDB

Q27027871-1F760165-46E3-42CC-A7EF-EC90A5298B3B

P3181

Q27027871-42553E3A-8B15-46FA-8C91-31470CD5A82E

P356

Q27027871-AB79FC5F-7756-46E9-A52D-02590F58FDF9

P407

Q27027871-A8B6409E-3C7F-4786-8DDB-7D106E5D0179

P433

Q27027871-C7623C14-749A-448E-A8D2-E3151BC041A6

P478

Q27027871-FF3E8395-0041-4228-A262-6C3D625301DF

P5008

Q27027871-D09E8383-C7AE-4E7F-9E07-F1B9E798BD12

P577

Q27027871-A2BBF56D-25D1-4453-B40E-4B945C7CB9CA

Q27027871-F92537DD-BF27-45BD-A8F8-3AF4EEDDEDA4

P5875

Q27027871-B66FC5FE-8EAB-408D-8C07-221F836DFE30

P698

Q27027871-3F7351B9-F656-46BE-94DA-65EBA39820A4

P921

Q27027871-000EBCF4-9FAB-4642-A498-6F4370A4C4BD

Q27027871-0E608A2D-2990-4A2E-9449-EFBF0D2FB5CD

Q27027871-AE2FBF63-93DF-480E-9B7F-367902E2D312

P932

Q27027871-AD663EC6-E714-4CA3-A0C7-DF17DC932744

P3181

P356

JOURNAL.PPAT.1003053

P1433

P1476

Determinants for the development of visceral leishmaniasis disease

@en

P2093

Greg Matlashewski

http://www.w3.org/2001/XMLSchema#string

Laura-Isobel McCall

http://www.w3.org/2001/XMLSchema#string

Wen-Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Leishmaniasis worldwide and global estimates of its incidence

Measuring the burden of neglected tropical diseases: the global burden of disease framework

Comparative genomic analysis of three Leishmania species that cause diverse human disease

Genetics and visceral leishmaniasis: of mice and man

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector

iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice

Vector transmission of leishmania abrogates vaccine-induced protective immunity

Visualisation of Leishmania donovani fluorescent hybrids during early stage development in the sand fly vector

Advances in leishmaniasis

P304

e1003053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4280913

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1003053

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234090049

http://www.w3.org/2001/XMLSchema#string

P698

23300451

http://www.w3.org/2001/XMLSchema#string

P921

Chin-hu̍t seng-bu̍t

visceral leishmaniasis

cutaneous leishmaniasis

P932

3536654

http://www.w3.org/2001/XMLSchema#string